This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Novo’s Inhaled Insulin Is Pulled From Further Research

Posted: Wednesday, May 05, 2004

Inhaled form of insulin fails to reach test goals, so Novo Nordisk A/S is pulling the plug.

Aradigm Corp., which is developing an inhaled form of insulin, said partner Novo Nordisk A/S is ending a study on the experimental treatment because it did not work as well as the injectable form. Shares fell as much as 37 percent. The AERx iDMS pulmonary-insulin treatment failed to reach goals of the study in Type-1 diabetics, which account for 5 percent to 10 percent of all diabetic patients in the United States. The trial was the final of three phases required for U.S. approval, Aradigm said Friday. Diabetes is a disease in which the body doesn't produce or properly use insulin, a hormone needed to convert sugar and food into energy

undefined undefined